Analysis of the structure of consumption of antiplatelet drugs in the Russian pharmaceutical market: 2014-2016
| Autor: | S. K. Zyryanov, E. V. Dumchenko |
|---|---|
| Jazyk: | ruština |
| Rok vydání: | 2018 |
| Předmět: |
исследование потребления лекарств
обзор потребления лекарственных средств фармацевтический рынок антитромбоцитарные препараты тиклопидин клопидогрел тикагрелор россия drug utilization research survey of drug usage survey of drug consumption pharmaceutical market antiplatelet drugs ticlopidine clopidogrel ticagrelor russia Medical technology R855-855.5 Pharmacy and materia medica RS1-441 |
| Zdroj: | Качественная клиническая практика, Vol 0, Iss 2, Pp 29-34 (2018) |
| Druh dokumentu: | article |
| ISSN: | 2588-0519 2618-8473 |
| Popis: | This article analyzes the volume of the Russian pharmaceutical market of antiplatelet drugs in the period 2014-2016. 80% of patients take clopidogrel generics, giving preference to Zilt®. Among the original drugs, the leaders of consumption are Plavix® and Coplavix® - in 2016 year 16%. In the structure of consumption of antiplatelet drugs, the share of original drugs as a whole account for about 60% of consumption in value terms, which is about 25% in packs. Clopidogrel generics (54% in value terms and 85% in natural terms) pass through the state segment, which means that most of the original drugs are purchased by patients through the retail pharmacy network, despite their high cost. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|